OliX Pharmaceuticals, Inc (KOSDAQ: 226950)

OliX Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 26, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	438,191	233,568	278,859	561,830	681,166	276,877
Market Cap Growth	-37.69%	-16.24%	-50.37%	-17.52%	146.02%	-37.76%
Enterprise Value	462,273	247,386	238,494	524,125	657,538	236,593
Last Close Price	25650.00	14580.00	20350.00	41000.00	50300.00	21200.00
PE Ratio	-	-11.01	-14.30	-18.88	-34.12	-19.23
PS Ratio	22.67	13.69	29.92	152.91	275.30	244.95
PB Ratio	16.66	4.64	4.21	28.95	15.02	6.62
P/FCF Ratio	-4.99	-7.79	-8.47	-27.62	-149.85	-23.58
P/OCF Ratio	-7.50	-11.03	-9.09	-29.49	-181.20	-25.80
EV/Sales Ratio	25.83	14.50	25.59	142.64	265.75	209.31
EV/EBITDA Ratio	-11.46	-15.92	-11.75	-23.19	-43.54	-16.50
EV/EBIT Ratio	-9.65	-13.60	-10.66	-21.63	-40.49	-15.65
EV/FCF Ratio	-15.85	-8.25	-7.25	-25.76	-144.65	-20.15
Debt / Equity Ratio	1.81	0.78	0.66	1.92	0.32	0.01
Debt / FCF Ratio	-1.64	-1.31	-1.34	-1.83	-3.20	-0.02
Asset Turnover	0.18	0.14	0.08	0.04	0.04	0.02
Inventory Turnover	0.30	0.28	0.40	0.51	0.17	0.11
Quick Ratio	0.86	4.71	1.59	1.24	15.21	12.98
Current Ratio	0.91	4.90	1.64	1.29	15.38	13.59
Return on Equity (ROE)	-57.19%	-32.78%	-65.68%	-90.11%	-44.48%	-29.67%
Return on Assets (ROA)	-10.35%	-9.65%	-12.75%	-18.33%	-16.40%	-18.74%
Return on Capital (ROIC)	-12.83%	-11.37%	-16.76%	-25.98%	-19.92%	-19.49%
Earnings Yield	-4.86%	-8.18%	-6.99%	-5.29%	-2.85%	-5.18%
FCF Yield	-6.66%	-12.84%	-11.80%	-3.62%	-0.67%	-4.24%
Buyback Yield / Dilution	-15.40%	-5.30%	-0.13%	-4.06%	-1.00%	-12.26%
Total Shareholder Return	-15.40%	-5.30%	-0.13%	-4.06%	-1.00%	-12.26%

Source: S&P Capital IQ. Standard template. Financial Sources.